SEC Tracker
Get the app
SMTI · XBRL financial data

Sanara MedTech financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (SMTI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers16,02517,690*18,53720,15921,67226,305*23,43425,83126,33427,546*27,79928,137
Cost of revenue1,7511,788*1,8902,0091,9922,249*1,8351,9371,8741,875*1,9241,981
Gross profit14,27415,902*16,64718,15019,68024,056*21,59923,89424,46025,671*25,87526,155
Research and development986652*9469861,3602,412*1,1141,2571,0302,036*7601,154
Selling, general and administrative13,87816,336*16,19218,95818,99322,417*21,44121,55319,87820,076*21,88222,602
General and administrative—————year only4,0453,957—year only4,8755,733
Total operating expenses15,18016,128*18,17821,03521,60424,431*23,67923,92521,51824,621*23,22824,375
Operating income (loss)(907)(226)*(1,532)(2,885)(1,924)(375)*(2,080)(31)2,9411,050*2,6471,780
Interest expense188287*2676449281,289*1,3171,7921,8181,833*1,7991,810
Other income (expense)(188)(36)*(267)(644)(959)(1,326)*(1,447)(1,987)(2,107)(2,158)*(2,249)(2,192)
Income tax expense (benefit)—————year only——————
Net income (loss)(1,060)(237)*(1,764)(3,504)(2,858)(1,539)*(3,527)(2,014)(30,411)(1,610)*459(453)
Earnings per share, basic USD per share(0.13)(0.03)*(0.21)(0.41)(0.34)(0.18)*(0.41)(0.23)(3.52)(0.19)*0.05(0.05)
Earnings per share, diluted USD per share(0.13)(0.03)*(0.21)(0.41)(0.34)(0.18)*(0.41)(0.23)(3.40)(0.19)*0.05(0.05)
Weighted average shares, basic thousands of shares8,3328,381*8,4208,4698,5178,530*8,5708,6138,6478,661*8,7078,663
Weighted average shares, diluted thousands of shares8,3328,381*8,4208,4698,5178,530*8,5708,6138,9418,367*8,9868,663

Balance sheet

CSV

Fiscal quarters (SMTI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents6,2365,1472,8286,15016,27715,87820,68816,95914,94016,57913,59415,421
Accounts receivable—————————11,99813,61712,573
Inventory5,0214,7184,2293,5653,0082,7533,1593,5123,3863,9493,1213,460
Prepaid and other current assets6226089124894291,1241,0911,200714949817742
Total current assets19,37519,00617,18720,81131,90833,30636,84333,66931,22633,54231,19832,201
Property and equipment, net1,3271,2581,1911,1169964322,0568,900417457459427
Right-of-use asset2,0941,9951,8951,7921,6891,4481,1741,0882,1552,0761,9941,909
Goodwill3,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,6023,602
Total assets75,47473,87170,91273,38488,54588,09296,37998,76871,08972,94469,27769,146
Accounts payable—————————2,339—1,401
Current portion of long-term debt232580929—————————
Total current liabilities13,22713,76812,74611,56614,34015,29013,28114,87617,35818,62713,70112,494
Long-term debt9,4589,1138,76814,37130,07730,68943,40244,21745,09045,97146,22646,477
Lease liability, non-current1,8461,7371,6261,5131,4071,2371,0881,0511,9631,8691,7711,670
Total liabilities31,37629,28327,90031,98249,09149,18059,71163,37664,94867,01462,25861,212
Accumulated deficit(27,800)(28,037)(29,898)(33,388)(36,246)(37,784)(41,312)(43,288)(73,694)(75,303)(74,503)(74,892)
Total stockholders' equity44,31744,83243,29141,70639,78439,40436,67135,3996,1495,9387,0297,943
Total liabilities and equity75,47473,87170,91273,38488,54588,09296,37998,76871,08972,94469,27769,146
Common shares outstanding (cover page) thousands of shares8,5388,6238,6258,7478,7418,9028,8888,9028,9369,1679,1649,188

Cash flows

CSV

Fiscal quarters (SMTI's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(1,060)(237)*(1,764)(3,504)(2,858)(1,539)*(3,527)(2,014)(30,411)(1,610)*459(453)
Stock-based compensation858861*8031,0831,0251,196*1,3051,4351,2321,182*1,0281,496*
Depreciation and amortization—————1,608*1,1241,114*1,039*668*587619*
Net cash from operating activities1,064*(849)*(1,594)(1,412)*2,050*932*(1,999)2,664*2,176*3,945*(2,465)2,038*
Purchases of property and equipment170*54*6659*9*72*1,7231,761*1,059*82*445*
Net cash from investing activities(10,113)*(54)*(66)(59)*(6,357)*(130)*(5,180)(3,928)*(3,421)*(2,445)*(44)(5)*
Net cash from financing activities9,225*(186)*(659)4,793*14,433*(1,201)*11,988(2,465)*(775)*139*(475)(206)*
Net change in cash176*(1,089)*(2,319)3,322*10,127*(399)*4,810(3,729)*(2,019)*1,639*(2,984)1,827*

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Sanara MedTech15,42128,1372,038*9.2M— 10-QJun 30, 2026
Anika Therapeutics38,41232,610(684)*13.4M56.2 quarters 10-QJun 30, 2026
Stereotaxis10,4917,670(3,675)*100.2M2.9 quarters 10-QJun 30, 2026
Profound Medical38,2712,483(11,338)*36.5M3.4 quarters 10-QJun 30, 2026
Sight Sciences79,75323,388(5,663)*55.1M14.1 quarters 10-QJun 30, 2026
AVITA Medical9,13921,702(3,496)*30.9M3.2 quarters 10-QJun 30, 2026
SkinHealth Systems206,07472,1132,671*130.1M— 10-QJun 30, 2026
Lakeland Industries17,90150,139(404)*9.9M— 10-QJul 31, 2026
Picard Medical382,954(1,352)*2.3M0.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.